Skip to main content
Unchecking box will stop auto data updates
CSE Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 4.090
Day High 4.270
Open:4.180
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Valens Groworks Corp is a Vancouver-based biotechnology company. It is primarily focused on medical strain genetics, organic cultivation and multiple product-development. The company operates in two related health Canada-licensed business segments involved in the scientific research of phytopharmaceutical material, specifically producing cannabis and cannabis-related products. Company operates in one business segment being the scientific research of phytopharmaceutical material, specifically producing cannabis and cannabis related products.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Lucrative High-Quality CBD Market Beckons Suppliers With Best Extraction Methods
PR Newswire - Thu Jun 20, 7:50AM CDT
PR Newswire - CMTX
Thu Jun 20, 7:50AM CDT
With each new market cannabidiol (CBD) expands into, an ever greater need for regulatory safeguards come into play to ensure safety and consistency of the quality of products in the market. This draws attention to the innovative extraction and production methods being developed and employed by CBD companies such as StillCanna Inc. (CSE:STIL) (OTC:SCNNF), Radient Technologies Inc. (TSX.V:RTI) (OTC:RDDTF), Valens GroWorks Corp. (CSE:VGW) (OTC:VGWCF), Neptune Wellness Solutions (NASDAQ:NEPT) (TSX:NEPT) and MediPharm Labs Corp. (OTC:MEDIF) (TSX.V:LABS).
1021916 B.C. Ltd Announces Management Changes
Newsfile Corp - Tue Jun 4, 11:48AM CDT
Newsfile Corp - CMTX
Tue Jun 4, 11:48AM CDT
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2019) - (the "") is pleased to announce Robert van Santen, Chris L. MacPherson and Leslie van Santen as the Company's new directors, and their appointments as Chief Executive Officer, Chief Financial Officer and Corporate Secretary respectively. These appointments replace the entire existing board of directors and officers effective immediately.
Numerous CBD and Cannabis Applications Position the Market for Worldwide Growth
PR Newswire - Fri May 17, 8:00AM CDT
PR Newswire - CMTX
Fri May 17, 8:00AM CDT
As the cannabis market continues to expand around the globe, research has confirmed that cannabidiol products are growing in popularity as well. Cowen & Co. analysts noted that nearly 7% of Americans are already using CBD-based product, clarifying that most consumers are using CBD as a supplement. Primarily, legal CBD is derived from the hemp plant, which falls under the cannabis family, while marijuana-derived CBD must comply with seed-to-sale state laws, which makes it illegal to transport products across state lines. However, hemp-derived CBD products are perfectly legal throughout almost every U.S. state as CBD is generally more accepted when compared to THC as it does not provide consumers with psychoactive effects. Despite the biological difference between THC and CBD, the two compounds are linked to providing similar therapeutic benefits. Clinical trials and research have suggested that CBD can suppress consumers' illnesses or symptoms associated with cancer, anxiety, chronic pain, and depression. Moreover, clinical trials have led to the U.S. Food and Drug Administration's approval of Epidiolex to treat two forms of childhood epilepsy. As a result, Cowen projects that CBD users will grow to 10% of U.S. adults or 25 million consumers by 2025. Consumers in the U.S. can easily find CBD products at their local stores and even pharmacies now. The growth of the CBD marketplace also compliments the THC marketplace, fueling recreational cannabis sales as well. The U.S. dominates the cannabis market as it accounts for the majority of the global share due to its early adoption. Furthermore, in combination with Canada's recent legalization, the North American region is already positioned to witness exponential growth. According to data compiled by IMARC Group, the North American legal cannabis market was valued at USD 8 Billion in 2017. By 2023, the market is projected to reach USD 35 Billion while registering a CAGR of 28% from 2018 to 2023. AREV Brands International Ltd. (OTC: AREVF) (CSE: AREV), Valens Groworks Corp. (OTC: VGWCF) (CSE: VGW), The Supreme Cannabis Co Inc. (OTC: SPRWF) (TSX: FIRE), Liberty Health Sciences Inc (OTC: LHSIF) (CSE: LHS), Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 3.370 +21.37% increase
on 06/17/19
Period Open:4.080
Price movement based on the high, low and last over the given period.
4.370 -6.41% decrease
on 05/28/19
+0.010 (+0.25%) increase
since 05/24/19
3-Month 2.830 +44.52% increase
on 04/02/19
Period Open:2.960
Price movement based on the high, low and last over the given period.
4.900 -16.53% decrease
on 04/30/19
+1.130 (+38.18%) increase
since 03/25/19
52-Week 0.980 +317.35% increase
on 07/26/18
Period Open:1.280
Price movement based on the high, low and last over the given period.
4.900 -16.53% decrease
on 04/30/19
+2.810 (+219.53%) increase
since 06/25/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).